Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
•This ESMO CPG provides diagnosis, staging, risk assessment, treatment and follow-up recommendations for cutaneous melanoma.•Algorithms for diagnosis, staging, management (stages I-IV and melanoma brain metastases) and follow-up are provided.•The authors comprise a multidisciplinary group of experts...
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2025-01, Vol.36 (1), p.10-30 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 30 |
|---|---|
| container_issue | 1 |
| container_start_page | 10 |
| container_title | Annals of oncology |
| container_volume | 36 |
| creator | Amaral, T. Ottaviano, M. Arance, A. Blank, C. Chiarion-Sileni, V. Donia, M. Dummer, R. Garbe, C. Gershenwald, J.E. Gogas, H. Guckenberger, M. Haanen, J. Hamid, O. Hauschild, A. Höller, C. Lebbé, C. Lee, R.J. Long, G.V. Lorigan, P. Muñoz Couselo, E. Nathan, P. Robert, C. Romano, E. Schadendorf, D. Sondak, V. Suijkerbuijk, K.P.M. van Akkooi, A.C.J. Michelin, O. Ascierto, P.A. |
| description | •This ESMO CPG provides diagnosis, staging, risk assessment, treatment and follow-up recommendations for cutaneous melanoma.•Algorithms for diagnosis, staging, management (stages I-IV and melanoma brain metastases) and follow-up are provided.•The authors comprise a multidisciplinary group of experts from Europe, USA and Australia.•Recommendations are based on current available scientific data and the authors’ collective expert opinion.•All recommendations should be discussed with patients and by a multidisciplinary team. |
| doi_str_mv | 10.1016/j.annonc.2024.11.006 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3129220706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753424049123</els_id><sourcerecordid>3129220706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1563-4ea4ff95d8373114d46f4093a14202ea027a86f252a7ca1a0b6d2ced08f19173</originalsourceid><addsrcrecordid>eNp9kE9v1DAQxS0EokvhGyDkIwcSxn-SrDkgoVUpSEVFojcO1tSeIK8Se7ETEN8elxSOnEaa-c3Me4-x5wJaAaJ_fWwxxhRdK0HqVogWoH_AdqLrTbMHLR6yHRipmqFT-ow9KeUIlTDSPGZnynQdgFI79vWwLhgprYXPNGFMM77hF18-XfPDFGJwOPHPGd0SHPHLNXiqXeJjytwH_BZTCeUVXzLhMlNcOEZfh9OUfjbr6Sl7NOJU6Nl9PWc37y9uDh-aq-vLj4d3V42rYlWjCfU4ms7v1aCE0F73owajUOhqjRDkgPt-lJ3EwaFAuO29dORhPwojBnXOXm5nTzl9X6ksdg7F0TRtvqwS0kgJA_QV1Rvqciol02hPOcyYf1kB9i5Ve7RbqvYuVSuEhT9rL-4_rLcz-X9Lf2OswNsNoGrzR6BsiwsUq8iQyS3Wp_D_D78BCqyJqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3129220706</pqid></control><display><type>article</type><title>Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up</title><source>Alma/SFX Local Collection</source><creator>Amaral, T. ; Ottaviano, M. ; Arance, A. ; Blank, C. ; Chiarion-Sileni, V. ; Donia, M. ; Dummer, R. ; Garbe, C. ; Gershenwald, J.E. ; Gogas, H. ; Guckenberger, M. ; Haanen, J. ; Hamid, O. ; Hauschild, A. ; Höller, C. ; Lebbé, C. ; Lee, R.J. ; Long, G.V. ; Lorigan, P. ; Muñoz Couselo, E. ; Nathan, P. ; Robert, C. ; Romano, E. ; Schadendorf, D. ; Sondak, V. ; Suijkerbuijk, K.P.M. ; van Akkooi, A.C.J. ; Michelin, O. ; Ascierto, P.A.</creator><creatorcontrib>Amaral, T. ; Ottaviano, M. ; Arance, A. ; Blank, C. ; Chiarion-Sileni, V. ; Donia, M. ; Dummer, R. ; Garbe, C. ; Gershenwald, J.E. ; Gogas, H. ; Guckenberger, M. ; Haanen, J. ; Hamid, O. ; Hauschild, A. ; Höller, C. ; Lebbé, C. ; Lee, R.J. ; Long, G.V. ; Lorigan, P. ; Muñoz Couselo, E. ; Nathan, P. ; Robert, C. ; Romano, E. ; Schadendorf, D. ; Sondak, V. ; Suijkerbuijk, K.P.M. ; van Akkooi, A.C.J. ; Michelin, O. ; Ascierto, P.A. ; ESMO Guidelines Committee ; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</creatorcontrib><description>•This ESMO CPG provides diagnosis, staging, risk assessment, treatment and follow-up recommendations for cutaneous melanoma.•Algorithms for diagnosis, staging, management (stages I-IV and melanoma brain metastases) and follow-up are provided.•The authors comprise a multidisciplinary group of experts from Europe, USA and Australia.•Recommendations are based on current available scientific data and the authors’ collective expert opinion.•All recommendations should be discussed with patients and by a multidisciplinary team.</description><identifier>ISSN: 0923-7534</identifier><identifier>ISSN: 1569-8041</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1016/j.annonc.2024.11.006</identifier><identifier>PMID: 39550033</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>cutaneous melanoma ; diagnosis ; ESMO Clinical Practice Guideline ; prognosis ; risk assessment ; treatment</subject><ispartof>Annals of oncology, 2025-01, Vol.36 (1), p.10-30</ispartof><rights>2024 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1563-4ea4ff95d8373114d46f4093a14202ea027a86f252a7ca1a0b6d2ced08f19173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39550033$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amaral, T.</creatorcontrib><creatorcontrib>Ottaviano, M.</creatorcontrib><creatorcontrib>Arance, A.</creatorcontrib><creatorcontrib>Blank, C.</creatorcontrib><creatorcontrib>Chiarion-Sileni, V.</creatorcontrib><creatorcontrib>Donia, M.</creatorcontrib><creatorcontrib>Dummer, R.</creatorcontrib><creatorcontrib>Garbe, C.</creatorcontrib><creatorcontrib>Gershenwald, J.E.</creatorcontrib><creatorcontrib>Gogas, H.</creatorcontrib><creatorcontrib>Guckenberger, M.</creatorcontrib><creatorcontrib>Haanen, J.</creatorcontrib><creatorcontrib>Hamid, O.</creatorcontrib><creatorcontrib>Hauschild, A.</creatorcontrib><creatorcontrib>Höller, C.</creatorcontrib><creatorcontrib>Lebbé, C.</creatorcontrib><creatorcontrib>Lee, R.J.</creatorcontrib><creatorcontrib>Long, G.V.</creatorcontrib><creatorcontrib>Lorigan, P.</creatorcontrib><creatorcontrib>Muñoz Couselo, E.</creatorcontrib><creatorcontrib>Nathan, P.</creatorcontrib><creatorcontrib>Robert, C.</creatorcontrib><creatorcontrib>Romano, E.</creatorcontrib><creatorcontrib>Schadendorf, D.</creatorcontrib><creatorcontrib>Sondak, V.</creatorcontrib><creatorcontrib>Suijkerbuijk, K.P.M.</creatorcontrib><creatorcontrib>van Akkooi, A.C.J.</creatorcontrib><creatorcontrib>Michelin, O.</creatorcontrib><creatorcontrib>Ascierto, P.A.</creatorcontrib><creatorcontrib>ESMO Guidelines Committee</creatorcontrib><creatorcontrib>ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</creatorcontrib><title>Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><description>•This ESMO CPG provides diagnosis, staging, risk assessment, treatment and follow-up recommendations for cutaneous melanoma.•Algorithms for diagnosis, staging, management (stages I-IV and melanoma brain metastases) and follow-up are provided.•The authors comprise a multidisciplinary group of experts from Europe, USA and Australia.•Recommendations are based on current available scientific data and the authors’ collective expert opinion.•All recommendations should be discussed with patients and by a multidisciplinary team.</description><subject>cutaneous melanoma</subject><subject>diagnosis</subject><subject>ESMO Clinical Practice Guideline</subject><subject>prognosis</subject><subject>risk assessment</subject><subject>treatment</subject><issn>0923-7534</issn><issn>1569-8041</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNp9kE9v1DAQxS0EokvhGyDkIwcSxn-SrDkgoVUpSEVFojcO1tSeIK8Se7ETEN8elxSOnEaa-c3Me4-x5wJaAaJ_fWwxxhRdK0HqVogWoH_AdqLrTbMHLR6yHRipmqFT-ow9KeUIlTDSPGZnynQdgFI79vWwLhgprYXPNGFMM77hF18-XfPDFGJwOPHPGd0SHPHLNXiqXeJjytwH_BZTCeUVXzLhMlNcOEZfh9OUfjbr6Sl7NOJU6Nl9PWc37y9uDh-aq-vLj4d3V42rYlWjCfU4ms7v1aCE0F73owajUOhqjRDkgPt-lJ3EwaFAuO29dORhPwojBnXOXm5nTzl9X6ksdg7F0TRtvqwS0kgJA_QV1Rvqciol02hPOcyYf1kB9i5Ve7RbqvYuVSuEhT9rL-4_rLcz-X9Lf2OswNsNoGrzR6BsiwsUq8iQyS3Wp_D_D78BCqyJqg</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Amaral, T.</creator><creator>Ottaviano, M.</creator><creator>Arance, A.</creator><creator>Blank, C.</creator><creator>Chiarion-Sileni, V.</creator><creator>Donia, M.</creator><creator>Dummer, R.</creator><creator>Garbe, C.</creator><creator>Gershenwald, J.E.</creator><creator>Gogas, H.</creator><creator>Guckenberger, M.</creator><creator>Haanen, J.</creator><creator>Hamid, O.</creator><creator>Hauschild, A.</creator><creator>Höller, C.</creator><creator>Lebbé, C.</creator><creator>Lee, R.J.</creator><creator>Long, G.V.</creator><creator>Lorigan, P.</creator><creator>Muñoz Couselo, E.</creator><creator>Nathan, P.</creator><creator>Robert, C.</creator><creator>Romano, E.</creator><creator>Schadendorf, D.</creator><creator>Sondak, V.</creator><creator>Suijkerbuijk, K.P.M.</creator><creator>van Akkooi, A.C.J.</creator><creator>Michelin, O.</creator><creator>Ascierto, P.A.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202501</creationdate><title>Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up</title><author>Amaral, T. ; Ottaviano, M. ; Arance, A. ; Blank, C. ; Chiarion-Sileni, V. ; Donia, M. ; Dummer, R. ; Garbe, C. ; Gershenwald, J.E. ; Gogas, H. ; Guckenberger, M. ; Haanen, J. ; Hamid, O. ; Hauschild, A. ; Höller, C. ; Lebbé, C. ; Lee, R.J. ; Long, G.V. ; Lorigan, P. ; Muñoz Couselo, E. ; Nathan, P. ; Robert, C. ; Romano, E. ; Schadendorf, D. ; Sondak, V. ; Suijkerbuijk, K.P.M. ; van Akkooi, A.C.J. ; Michelin, O. ; Ascierto, P.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1563-4ea4ff95d8373114d46f4093a14202ea027a86f252a7ca1a0b6d2ced08f19173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>cutaneous melanoma</topic><topic>diagnosis</topic><topic>ESMO Clinical Practice Guideline</topic><topic>prognosis</topic><topic>risk assessment</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amaral, T.</creatorcontrib><creatorcontrib>Ottaviano, M.</creatorcontrib><creatorcontrib>Arance, A.</creatorcontrib><creatorcontrib>Blank, C.</creatorcontrib><creatorcontrib>Chiarion-Sileni, V.</creatorcontrib><creatorcontrib>Donia, M.</creatorcontrib><creatorcontrib>Dummer, R.</creatorcontrib><creatorcontrib>Garbe, C.</creatorcontrib><creatorcontrib>Gershenwald, J.E.</creatorcontrib><creatorcontrib>Gogas, H.</creatorcontrib><creatorcontrib>Guckenberger, M.</creatorcontrib><creatorcontrib>Haanen, J.</creatorcontrib><creatorcontrib>Hamid, O.</creatorcontrib><creatorcontrib>Hauschild, A.</creatorcontrib><creatorcontrib>Höller, C.</creatorcontrib><creatorcontrib>Lebbé, C.</creatorcontrib><creatorcontrib>Lee, R.J.</creatorcontrib><creatorcontrib>Long, G.V.</creatorcontrib><creatorcontrib>Lorigan, P.</creatorcontrib><creatorcontrib>Muñoz Couselo, E.</creatorcontrib><creatorcontrib>Nathan, P.</creatorcontrib><creatorcontrib>Robert, C.</creatorcontrib><creatorcontrib>Romano, E.</creatorcontrib><creatorcontrib>Schadendorf, D.</creatorcontrib><creatorcontrib>Sondak, V.</creatorcontrib><creatorcontrib>Suijkerbuijk, K.P.M.</creatorcontrib><creatorcontrib>van Akkooi, A.C.J.</creatorcontrib><creatorcontrib>Michelin, O.</creatorcontrib><creatorcontrib>Ascierto, P.A.</creatorcontrib><creatorcontrib>ESMO Guidelines Committee</creatorcontrib><creatorcontrib>ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amaral, T.</au><au>Ottaviano, M.</au><au>Arance, A.</au><au>Blank, C.</au><au>Chiarion-Sileni, V.</au><au>Donia, M.</au><au>Dummer, R.</au><au>Garbe, C.</au><au>Gershenwald, J.E.</au><au>Gogas, H.</au><au>Guckenberger, M.</au><au>Haanen, J.</au><au>Hamid, O.</au><au>Hauschild, A.</au><au>Höller, C.</au><au>Lebbé, C.</au><au>Lee, R.J.</au><au>Long, G.V.</au><au>Lorigan, P.</au><au>Muñoz Couselo, E.</au><au>Nathan, P.</au><au>Robert, C.</au><au>Romano, E.</au><au>Schadendorf, D.</au><au>Sondak, V.</au><au>Suijkerbuijk, K.P.M.</au><au>van Akkooi, A.C.J.</au><au>Michelin, O.</au><au>Ascierto, P.A.</au><aucorp>ESMO Guidelines Committee</aucorp><aucorp>ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2025-01</date><risdate>2025</risdate><volume>36</volume><issue>1</issue><spage>10</spage><epage>30</epage><pages>10-30</pages><issn>0923-7534</issn><issn>1569-8041</issn><eissn>1569-8041</eissn><abstract>•This ESMO CPG provides diagnosis, staging, risk assessment, treatment and follow-up recommendations for cutaneous melanoma.•Algorithms for diagnosis, staging, management (stages I-IV and melanoma brain metastases) and follow-up are provided.•The authors comprise a multidisciplinary group of experts from Europe, USA and Australia.•Recommendations are based on current available scientific data and the authors’ collective expert opinion.•All recommendations should be discussed with patients and by a multidisciplinary team.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39550033</pmid><doi>10.1016/j.annonc.2024.11.006</doi><tpages>21</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2025-01, Vol.36 (1), p.10-30 |
| issn | 0923-7534 1569-8041 1569-8041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3129220706 |
| source | Alma/SFX Local Collection |
| subjects | cutaneous melanoma diagnosis ESMO Clinical Practice Guideline prognosis risk assessment treatment |
| title | Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T07%3A51%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutaneous%20melanoma:%20ESMO%20Clinical%20Practice%20Guideline%20for%20diagnosis,%20treatment%20and%20follow-up&rft.jtitle=Annals%20of%20oncology&rft.au=Amaral,%20T.&rft.aucorp=ESMO%20Guidelines%20Committee&rft.date=2025-01&rft.volume=36&rft.issue=1&rft.spage=10&rft.epage=30&rft.pages=10-30&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1016/j.annonc.2024.11.006&rft_dat=%3Cproquest_cross%3E3129220706%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3129220706&rft_id=info:pmid/39550033&rft_els_id=S0923753424049123&rfr_iscdi=true |